NEOGENNSENeogen Chemicals LimitedHighPositive
Announced Sat, 17 May · 21:51 IST

Neogen Chemicals Limited has informed the Exchange regarding outcome of Board meeting held on May 17, 2025 which includes 1) Approval of Audited financial results for the quarter and FY ended 31-03-2025 with regulation Regulation 33(3)(d) declaration 2)recommendation of dividend 3)Appointment of Secretarial Auditor 4) Details of Outstanding Qualified Borrowings and Incremental Qualified Borrowings for FY 2025 5) Incorporation of Wholly owned subsidiary by Neogen�Ionics�Limited.

Emphasis Of MatterResults RestatedExceptional ItemResults View source PDF

NEOGEN · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

The Board approved audited financial results for Q4 and FY ended March 31, 2025, with the auditor issuing an unmodified opinion. Standalone FY25 revenue grew to ₹773.65 crores (from ₹701.42 crores restated) and profit after tax rose to ₹48.41 crores (from ₹41.13 crores), while Q4 revenue declined slightly to ₹203.75 crores. A final dividend of Re. 1 per share was recommended. The auditor flagged a fire at the Dahej SEZ Plant (March 5, 2025) as an Emphasis of Matter — a net loss of ₹13.56 crores (standalone) after netting ₹348.16 crores of fire losses against ₹334.60 crores of insurance claim has been shown as an exceptional item. Prior period figures have been restated to reflect the merger of wholly owned subsidiary Buli Chemicals India, effective January 31, 2025. The Board also approved the incorporation of a new wholly owned subsidiary, Neogen Morita New Materials Limited, under Neogen Ionics, to enter the lithium-ion battery electrolyte salts space via a proposed joint venture with Japan's Morita Chemicals Industries.

Likely market impact

Results are broadly steady with revenue and profit growth on a restated basis, though the Dahej plant fire remains a key overhang pending the final insurance surveyor report. The small final dividend and capital being directed into a new battery materials venture signal modest shareholder returns but a forward-looking growth push in the EV chemicals space.